{"id":471419,"date":"2021-04-06T07:03:32","date_gmt":"2021-04-06T11:03:32","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=471419"},"modified":"2021-04-06T07:03:32","modified_gmt":"2021-04-06T11:03:32","slug":"pyc-therapeutics-to-host-quarterly-investor-call-on-april-15th-800am-awst-10am-aest","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/pyc-therapeutics-to-host-quarterly-investor-call-on-april-15th-800am-awst-10am-aest\/","title":{"rendered":"PYC Therapeutics to Host Quarterly Investor Call on April 15th 8:00am AWST | 10am AEST"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n NEW YORK<\/span> and PERTH, Australia<\/span>, April 6, 2021<\/span> \/PRNewswire\/ — PYC Therapeutics (ASX: PYC), a biotechnology company developing a new generation of precision RNA therapeutics to change the lives of patients with inherited diseases, today announced it will host an investor call on April 15, 2021<\/span> at 10 am<\/span> AEST | 8 am<\/span> AWST (April 14<\/span>, 8pm<\/span> U.S. ET) to discuss corporate and pipeline updates.<\/p>\n

\n

\n
\n \"(PRNewsfoto\/PYC
\n <\/a>\n <\/p>\n<\/p><\/div>\n

Attendees can submit questions ahead of the call via email to info@pyctx.com<\/a> and register for the call here: <\/p>\n

\n https:\/\/zoom.us\/meeting\/register\/tJ0ofuyrpjgpHt2K-x63xctoRuApZRlTvIJM<\/a>\u00a0<\/p>\n

A link to the call will be available in the “Events” section on the “Investor & media center” page of the PYC website at\u00a0https:\/\/pyctx.com\/investor-center\/<\/a> and a recording will also be made available at this location after the call.<\/p>\n

\n About PYC Therapeutics<\/b>\n <\/p>\n

PYC Therapeutics (ASX: PYC) is a development-stage biotechnology company pioneering a new generation of RNA therapeutics that utilize Cell Penetrating Peptides (CPPs), a revolutionary delivery technology designed to overcome the major challenges of current gene-based therapies. PYC believes its CPP technology provides safer, more effective access for a wide range of potent and precise drug cargoes to the highest value drug targets that exist inside cells. The Company is leveraging its leading-edge science to develop a pipeline of novel therapies with an initial focus on inherited eye diseases for which it has unveiled three preclinical stage assets. PYC’s discovery and laboratory operations are located in Australia<\/span> and the Company recently launched an expansion into the U.S. for its preclinical, clinical, regulatory and business development operations.\u00a0 For more information, visit pyctx.com<\/a>, or follow us on LinkedIn<\/a> and Twitter<\/a>.<\/p>\n

\n Forward looking statements<\/b>\n <\/p>\n

\n Any forward-looking statements in this ASX announcement have been prepared on the basis of a number of assumptions which may prove incorrect and the current intentions, plans, expectations and beliefs about future events are subject to risks, uncertainties and other factors, many of which are outside the Company’s control. Important factors that could cause actual results to differ materially from assumptions or expectations expressed or implied in this ASX announcement include known and unknown risks. Because actual results could differ materially to assumptions made and the Company’s current intentions, plans, expectations and beliefs about the future, you are urged to view all forward-looking statements contained in this ASX announcement with caution.\u00a0 The Company undertakes no obligation to publicly update any forward-looking statement whether as a result of new information, future events or otherwise.<\/i>\n <\/p>\n

\n\n\n\n\n\n\n\n\n
\n

\n
\n CONTACTS:<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n \n <\/td>\n<\/tr>\n
\n \n <\/td>\n\n \n <\/td>\n<\/tr>\n
\n

\n
\n INVESTORS<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n MEDIA<\/b>
\n <\/span>\n <\/p>\n

\n Leo Vartorella<\/span>\n <\/p>\n

\n Argot Partners<\/span>\n <\/p>\n

\n
\n leo@argotpartners.com<\/a>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Deborah Elson\/Matthew DeYoung<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Argot Partners <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n deborah@argotpartners.com<\/a>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n matthew@argotpartners.com<\/a>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

\u00a0<\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:http:\/\/www.prnewswire.com\/news-releases\/pyc-therapeutics-to-host-quarterly-investor-call-on-april-15th-800am-awst–10am-aest-301261086.html<\/a><\/p>\n

SOURCE PYC Therapeutics<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire NEW YORK and PERTH, Australia, April 6, 2021 \/PRNewswire\/ — PYC Therapeutics (ASX: PYC), a biotechnology company developing a new generation of precision RNA therapeutics to change the lives of patients with inherited diseases, today announced it will host an investor call on April 15, 2021 at 10 am AEST | 8 am AWST (April 14, 8pm U.S. ET) to discuss corporate and pipeline updates. Attendees can submit questions ahead of the call via email to info@pyctx.com and register for the call here: https:\/\/zoom.us\/meeting\/register\/tJ0ofuyrpjgpHt2K-x63xctoRuApZRlTvIJM\u00a0 A link to the call will be available in the “Events” section on the “Investor & media center” page of the PYC website at\u00a0https:\/\/pyctx.com\/investor-center\/ and a recording will also be made available at this … <\/p>\n

Continue reading “PYC Therapeutics to Host Quarterly Investor Call on April 15th 8:00am AWST | 10am AEST”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-471419","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nPYC Therapeutics to Host Quarterly Investor Call on April 15th 8:00am AWST | 10am AEST - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/pyc-therapeutics-to-host-quarterly-investor-call-on-april-15th-800am-awst-10am-aest\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PYC Therapeutics to Host Quarterly Investor Call on April 15th 8:00am AWST | 10am AEST - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK and PERTH, Australia, April 6, 2021 \/PRNewswire\/ — PYC Therapeutics (ASX: PYC), a biotechnology company developing a new generation of precision RNA therapeutics to change the lives of patients with inherited diseases, today announced it will host an investor call on April 15, 2021 at 10 am AEST | 8 am AWST (April 14, 8pm U.S. ET) to discuss corporate and pipeline updates. Attendees can submit questions ahead of the call via email to info@pyctx.com and register for the call here: https:\/\/zoom.us\/meeting\/register\/tJ0ofuyrpjgpHt2K-x63xctoRuApZRlTvIJM\u00a0 A link to the call will be available in the “Events” section on the “Investor & media center” page of the PYC website at\u00a0https:\/\/pyctx.com\/investor-center\/ and a recording will also be made available at this … Continue reading "PYC Therapeutics to Host Quarterly Investor Call on April 15th 8:00am AWST | 10am AEST"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/pyc-therapeutics-to-host-quarterly-investor-call-on-april-15th-800am-awst-10am-aest\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-06T11:03:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1436960\/PYC_Therapeutics_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pyc-therapeutics-to-host-quarterly-investor-call-on-april-15th-800am-awst-10am-aest\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pyc-therapeutics-to-host-quarterly-investor-call-on-april-15th-800am-awst-10am-aest\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"PYC Therapeutics to Host Quarterly Investor Call on April 15th 8:00am AWST | 10am AEST\",\"datePublished\":\"2021-04-06T11:03:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pyc-therapeutics-to-host-quarterly-investor-call-on-april-15th-800am-awst-10am-aest\\\/\"},\"wordCount\":464,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pyc-therapeutics-to-host-quarterly-investor-call-on-april-15th-800am-awst-10am-aest\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1436960\\\/PYC_Therapeutics_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pyc-therapeutics-to-host-quarterly-investor-call-on-april-15th-800am-awst-10am-aest\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pyc-therapeutics-to-host-quarterly-investor-call-on-april-15th-800am-awst-10am-aest\\\/\",\"name\":\"PYC Therapeutics to Host Quarterly Investor Call on April 15th 8:00am AWST | 10am AEST - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pyc-therapeutics-to-host-quarterly-investor-call-on-april-15th-800am-awst-10am-aest\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pyc-therapeutics-to-host-quarterly-investor-call-on-april-15th-800am-awst-10am-aest\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1436960\\\/PYC_Therapeutics_Logo.jpg\",\"datePublished\":\"2021-04-06T11:03:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pyc-therapeutics-to-host-quarterly-investor-call-on-april-15th-800am-awst-10am-aest\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pyc-therapeutics-to-host-quarterly-investor-call-on-april-15th-800am-awst-10am-aest\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pyc-therapeutics-to-host-quarterly-investor-call-on-april-15th-800am-awst-10am-aest\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1436960\\\/PYC_Therapeutics_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1436960\\\/PYC_Therapeutics_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pyc-therapeutics-to-host-quarterly-investor-call-on-april-15th-800am-awst-10am-aest\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PYC Therapeutics to Host Quarterly Investor Call on April 15th 8:00am AWST | 10am AEST\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PYC Therapeutics to Host Quarterly Investor Call on April 15th 8:00am AWST | 10am AEST - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/pyc-therapeutics-to-host-quarterly-investor-call-on-april-15th-800am-awst-10am-aest\/","og_locale":"en_US","og_type":"article","og_title":"PYC Therapeutics to Host Quarterly Investor Call on April 15th 8:00am AWST | 10am AEST - Market Newsdesk","og_description":"PR Newswire NEW YORK and PERTH, Australia, April 6, 2021 \/PRNewswire\/ — PYC Therapeutics (ASX: PYC), a biotechnology company developing a new generation of precision RNA therapeutics to change the lives of patients with inherited diseases, today announced it will host an investor call on April 15, 2021 at 10 am AEST | 8 am AWST (April 14, 8pm U.S. ET) to discuss corporate and pipeline updates. Attendees can submit questions ahead of the call via email to info@pyctx.com and register for the call here: https:\/\/zoom.us\/meeting\/register\/tJ0ofuyrpjgpHt2K-x63xctoRuApZRlTvIJM\u00a0 A link to the call will be available in the “Events” section on the “Investor & media center” page of the PYC website at\u00a0https:\/\/pyctx.com\/investor-center\/ and a recording will also be made available at this … Continue reading \"PYC Therapeutics to Host Quarterly Investor Call on April 15th 8:00am AWST | 10am AEST\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/pyc-therapeutics-to-host-quarterly-investor-call-on-april-15th-800am-awst-10am-aest\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-06T11:03:32+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1436960\/PYC_Therapeutics_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pyc-therapeutics-to-host-quarterly-investor-call-on-april-15th-800am-awst-10am-aest\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pyc-therapeutics-to-host-quarterly-investor-call-on-april-15th-800am-awst-10am-aest\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"PYC Therapeutics to Host Quarterly Investor Call on April 15th 8:00am AWST | 10am AEST","datePublished":"2021-04-06T11:03:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pyc-therapeutics-to-host-quarterly-investor-call-on-april-15th-800am-awst-10am-aest\/"},"wordCount":464,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pyc-therapeutics-to-host-quarterly-investor-call-on-april-15th-800am-awst-10am-aest\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1436960\/PYC_Therapeutics_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pyc-therapeutics-to-host-quarterly-investor-call-on-april-15th-800am-awst-10am-aest\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/pyc-therapeutics-to-host-quarterly-investor-call-on-april-15th-800am-awst-10am-aest\/","name":"PYC Therapeutics to Host Quarterly Investor Call on April 15th 8:00am AWST | 10am AEST - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pyc-therapeutics-to-host-quarterly-investor-call-on-april-15th-800am-awst-10am-aest\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pyc-therapeutics-to-host-quarterly-investor-call-on-april-15th-800am-awst-10am-aest\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1436960\/PYC_Therapeutics_Logo.jpg","datePublished":"2021-04-06T11:03:32+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pyc-therapeutics-to-host-quarterly-investor-call-on-april-15th-800am-awst-10am-aest\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/pyc-therapeutics-to-host-quarterly-investor-call-on-april-15th-800am-awst-10am-aest\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pyc-therapeutics-to-host-quarterly-investor-call-on-april-15th-800am-awst-10am-aest\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1436960\/PYC_Therapeutics_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1436960\/PYC_Therapeutics_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pyc-therapeutics-to-host-quarterly-investor-call-on-april-15th-800am-awst-10am-aest\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"PYC Therapeutics to Host Quarterly Investor Call on April 15th 8:00am AWST | 10am AEST"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/471419","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=471419"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/471419\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=471419"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=471419"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=471419"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}